Moxifloxacin HCl IP. eq. to Moxifloxacin 0.5% w/v Ketorolac Tromethamine IP. 0.5% w/vMovilox-D

Eye dropsPacking : 5 ml

Composition- Moxifloxacin HCl IP. eq. to Moxifloxacin 0.5% w/v Ketorolac Tromethamine IP. 0.5% w/v

MRP : 79.59/-

Prescribed By : Ophthalmologist, General Physician

Product Description

Key Benefits of Movilox-D

Reaches the eye surface at a concentration no oral antibiotic could
Broad cover against the organisms that cause eye infection
Controls inflammation without the pressure rise a steroid can cause
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch

Indications of Movilox-D

Bacterial conjunctivitis
Corneal ulcer
Blepharitis
Eye infection after surgery or injury
Eye pain and inflammation

How Movilox-D works

This is a combination, and each component handles a different part of the problem. Moxifloxacin blocks DNA gyrase and topoisomerase IV, the enzymes bacteria need to unwind and copy their DNA. Replication stops and the organism dies. Instilled directly into the eye, the drug reaches the cornea and conjunctiva at concentrations no tablet could produce there, while almost nothing enters the bloodstream. Moxifloxacin is a fourth-generation fluoroquinolone, which means it acts on both bacterial enzymes at once rather than one. Resistance requires two separate mutations instead of one, so it develops far more slowly. Ketorolac inhibits cyclo-oxygenase in the eye, cutting off the prostaglandins that cause pain, redness and swelling. Unlike a steroid it does not raise intraocular pressure, which is what makes it useful where inflammation has to be controlled without that risk. One preparation therefore does what would otherwise take two.

Why ChooseMovilox-D?

Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Preparations for the eye are made under controlled conditions with attention to sterility, pH and tonicity, because a preparation that stings or irritates simply will not be used as prescribed. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.

Frequently asked questions about Movilox-D

Is monopoly available for this product?

Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.

What is the composition of Movilox-D?

Moxifloxacin HCl IP. eq. to Moxifloxacin 0.5% w/v Ketorolac Tromethamine IP. 0.5% w/v.

Is this manufactured at a WHO-GMP certified facility?

Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.

What is the minimum order quantity?

Please contact our team for the current MOQ and price structure for your territory.

Last updated on 29 August 2026

This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.